Breaks Categories: News

FridayJun 03, 2022 3:01 pm

NetworkNewsBreaks – Riot Blockchain Inc. (NASDAQ: RIOT) Releases Production, Operation Status Report for May 2022

Riot Blockchain (NASDAQ: RIOT), an industry leader in Bitcoin mining and hosting, is reporting on its May 2022 productions and operations status. A highlight of the report includes the company’s production of 466 BTC, an estimated 104% increase over May 2021’s production of production of 228 BTC. In addition, the company reported that it held approximately 6,536 BTC, all produced by the Company’s self-mining operations, and sold 250 Bitcoin, generating net proceeds of approximately $7.5 million. Finally, the company reported a deployed fleet of some 43,458 miners, with a hash rate capacity of 4.6 exahash per second (“EH/s”). The company…

Continue Reading

FridayJun 03, 2022 2:57 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Details for 2022 LD Micro Invitational

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced details for the 2022 LD Micro Invitational. SRAX will host the prominent investor conference on June 7-9 at the Four Seasons Hotel Westlake Village, as well as via its Sequire Virtual Events platform. LD Micro is the host of the most influential conferences in the small-cap world. Following last October’s success of the LD Micro Main Event, SRAX is providing a virtual option for those unable to attend the physical conference. The event, which expects to…

Continue Reading

FridayJun 03, 2022 2:48 pm

NetworkNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Strong Q2 Financial Results

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, today announced financial results for its second fiscal quarter ended April 30, 2022. Among the highlights, the company reported Q2 revenues of $8,482,743, a 221% increase as compared to the same quarter last year. The company also noted 15 consecutive quarters of profitability. “We are pleased with the financial results of our second quarter as a company with both B2B and B2C verticals,” said Golden Matrix CEO Brian Goodman. “During the quarter we implemented upgraded technology and stronger accounting controls to improve cash…

Continue Reading

FridayJun 03, 2022 2:36 pm

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Announces Filing of New Patent Application for Green Ammonia and Hydrogen Technology

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) today announced that it has filed a U.S. non-provisional patent application for the company’s “Modular Transportable Clean Hydrogen-Ammonia Maker” with the United States Patent and Trademark Office. This claims priority out of FuelPositive’s U.S. provisional patent application filed on June 7, 2021, and elaborates upon FuelPositive’s inventive concepts. “We continue to refine our proprietary systems and apparatus in the process of constructing our demonstration systems,” said Ian Clifford, CEO and board chair of FuelPositive. “There is a worldwide shortage of ammonia and fertilizer and seriously compromised supply chains, making our decentralized and containerized on-site green…

Continue Reading

FridayJun 03, 2022 2:27 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards Exclusive License to Japan’s Premier Wellness Science Co.

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has awarded licensing of its proprietary DehydraTECH(TM) offering for development in Japan to Premier Wellness Science Co. Ltd, a wholly owned subsidiary of Premier Anti-Aging Co. Ltd. LEXX announced that Premier is purchasing exclusive rights to DehydraTECH technology for the Japanese nonpharmaceutical market; the company will use the tech in oral liquid and nonliquid products, as well as for topical, hair-care, lip-care and cosmetics products. According to the announcement, Lexaria will receive minimum payments of $4,527,500 over the next five years, as all well as royalties from the sales of products…

Continue Reading

FridayJun 03, 2022 2:05 pm

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) EMBARK Program Spotlighted in “Frontiers in Psychology” Article

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), and its proprietary EMBARK program is the focus of a recent article in the “Frontiers in Psychology” journal. The peer-reviewed article discusses the company’s model of psychedelic-assisted psychotherapy that integrates leading clinical approaches to promote effective facilitation and supportive healing with psychedelic medicines. Titled “Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model,” the article appears in the June 2, 2022, issue of the publication, which is the largest journal in the field of psychology. The article discusses EMBARK’s…

Continue Reading

FridayJun 03, 2022 1:42 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) CEO to Appear on Benzinga’s ‘All Access’ Series

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its CEO and chair David Michery are spotlighted during an interview on Benzinga’s All Access Series. The interview is slated for today, June 3, 2022, at 11 a.m. ET. Michery and All Access host Spencer Israel will discuss the company, including its upcoming “Strikingly Different” U.S. test drive tour, which will include stops at 19 cities across the country. Benzinga’s All Access show is a valuable source for those who want to learn more about the latest-trending stocks and investment opportunities. The show features live CEO interviews, due diligence…

Continue Reading

FridayJun 03, 2022 1:24 pm

NetworkNewsBreaks – Elektros Inc. (ELEK) Announces Filing of Patent Pending for EV Portable Battery Technology

Elektros (OTC: ELEK), an emerging leader in the electric vehicle industry, has announced that the company filed a patent pending last week with the United States Patent and Trademark Office for a revolutionary portable battery technology. According to the update, Elektros aims to perfect this technology over the next year to make it compatible with all Tesla models and other electric vehicles such as the Mercedes-Benz EQS. The portable battery contains an extension cord and allows consumers to plug in their electric vehicles at any time or place in case they do not have access to a traditional electric vehicle…

Continue Reading

ThursdayJun 02, 2022 2:13 pm

NetworkNewsBreaks – Riot Blockchain Inc. (NASDAQ: RIOT) Names New CFO, Outlines Other Financial Succession Appointments

Riot Blockchain (NASDAQ: RIOT), an industry leader in Bitcoin mining and hosting, has named a new chief financial officer. Colin Yee, currently serving as head of corporate & financial operations, has been appointed by the company’s board of directors to serve as CFO, effective Aug. 15, 2022. Yee replaces Jeff McGonegal, who is retiring after 20 years with the company. McGonegal will continue to serve in the capacity of senior advisor, and will remain employed through the term of his employment agreement of Feb. 7, 2023; after that time, it is anticipated that he will enter into a consulting agreement…

Continue Reading

ThursdayJun 02, 2022 2:03 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH Footprint Extends to Europe with License Granted to Valcon Medical

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has awarded licensing of its proprietary DehydraTECH(TM) offering for development in the European and United Kingdom markets. The company awarded the nonexclusive licenses to Valcon Medical A/S, a European contract manufacturing organization that specializes in the manufacturing of medical cannabis extracts for the EU and UK. According to the announcement, Lexaria will receive milestone fees and royalty payments from sales of products manufactured by Valcon.Valcon products will include an array of options, from nonregistered medical products through magistral programs to country-level market-authorized medical cannabis products through pilot programs; they will…

Continue Reading